Gabrielle Couchy

11.4k total citations · 4 hit papers
64 papers, 6.1k citations indexed

About

Gabrielle Couchy is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Gabrielle Couchy has authored 64 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 25 papers in Pulmonary and Respiratory Medicine and 23 papers in Cancer Research. Recurrent topics in Gabrielle Couchy's work include Renal cell carcinoma treatment (22 papers), Renal and related cancers (18 papers) and Cancer Genomics and Diagnostics (15 papers). Gabrielle Couchy is often cited by papers focused on Renal cell carcinoma treatment (22 papers), Renal and related cancers (18 papers) and Cancer Genomics and Diagnostics (15 papers). Gabrielle Couchy collaborates with scholars based in France, Belgium and United States. Gabrielle Couchy's co-authors include Jessica Zucman‐Rossi, Paulette Bioulac‐Sage, Charles Balabaud, Sandrine Imbeaud, Sandra Rebouissou, Julien Caldéraro, Éric Letouzé, Jean‐Frédéric Blanc, Jean‐Charles Nault and Yannick Ladeiro and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Gabrielle Couchy

63 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma

2012 1.1k citations Sandrine Imbeaud, Julien Caldéraro et al. profile →
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations

2008 570 citations Gabrielle Couchy, Charles Balabaud et al. profile →
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification

2017 532 citations Julien Caldéraro, Gabrielle Couchy et al. Journal of Hepatology profile →
Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas

2015 369 citations Jean‐Charles Nault, Sandrine Imbeaud et al. profile →

Peers

Gabrielle Couchy

HEPAT

ONCOL

EPIDE

Sandra Rebouissou France

Éric Letouzé France

Qing‐Hai Ye China

Zhao–You Tang China

Zhao‐Chong Zeng China

Hu‐Liang Jia China

Marshonna Forgues United States

David S. Rickman United States

ST Cheung Hong Kong

Luca Di Tommaso Italy

Sandra Rebouissou France

Gabrielle Couchy

2.5k ×0.8

1.6k ×0.8

1.8k ×0.9

HEPAT

1.0k ×0.7

ONCOL

994 ×0.8

EPIDE

Citations per year, relative to Gabrielle Couchy Gabrielle Couchy (= 1×) peers Sandra Rebouissou

Countries citing papers authored by Gabrielle Couchy

Since Specialization

Citations

This map shows the geographic impact of Gabrielle Couchy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabrielle Couchy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabrielle Couchy more than expected).

Fields of papers citing papers by Gabrielle Couchy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabrielle Couchy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabrielle Couchy. The network helps show where Gabrielle Couchy may publish in the future.

Co-authorship network of co-authors of Gabrielle Couchy

This figure shows the co-authorship network connecting the top 25 collaborators of Gabrielle Couchy. A scholar is included among the top collaborators of Gabrielle Couchy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabrielle Couchy. Gabrielle Couchy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Campani, Claudia, Sandrine Imbeaud, Gabrielle Couchy, et al.. (2024). Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments. Gut. 73(11). 1870–1882. 21 indexed citations

Kinget, Lisa, Eduard Roussel, Philip R. Debruyne, et al.. (2024). Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab. Acta Oncologica. 63. 658–668. 2 indexed citations

Poté, Nicolas, Stefano Caruso, François Cauchy, et al.. (2023). Borderline Hepatocellular Adenomas: A Practical Diagnostic Approach Based on Pathologic and Molecular Features. Modern Pathology. 36(9). 100211–100211. 7 indexed citations

Kinget, Lisa, Eduard Roussel, Annelies Verbiest, et al.. (2021). MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma. Cancers. 13(12). 3099–3099. 19 indexed citations

Kinget, Lisa, Eduard Roussel, Diether Lambrechts, et al.. (2021). MicroRNAs Possibly Involved in the Development of Bone Metastasis in Clear-Cell Renal Cell Carcinoma. Cancers. 13(7). 1554–1554. 11 indexed citations

Verbiest, Annelies, Vincent van Hoef, Cristina Rodríguez‐Antona, et al.. (2020). MicroRNA expression profiles in molecular subtypes of clear-cell renal cell carcinoma are associated with clinical outcome and repression of specific mRNA targets. PLoS ONE. 15(9). e0238809–e0238809. 5 indexed citations

Gérard, Claude, Stefano Caruso, Gabrielle Couchy, et al.. (2019). Dynamics and predicted drug response of a gene network linking dedifferentiation with beta-catenin dysfunction in hepatocellular carcinoma. Journal of Hepatology. 71(2). 323–332. 10 indexed citations

Caruso, Stefano, Romain Donné, Séverine Celton‐Morizur, et al.. (2019). Polyploidy spectrum: a new marker in HCC classification. Gut. 69(2). 355–364. 72 indexed citations

Caruso, Stefano, Tiziana La Bella, Sandrine Imbeaud, et al.. (2019). Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response. Gastroenterology. 157(3). 760–776. 133 indexed citations

10.

Punie, Kevin, Liesbeth De Wever, Marcella Baldewijns, et al.. (2019). Immunogenomics of Metastatic Clear-Cell Renal Cell Carcinoma: Remarkable Response to Nivolumab in a Patient With a Pathogenic Germ Line BRCA1 Mutation. Clinical Genitourinary Cancer. 17(5). e909–e912. 1 indexed citations

11.

Verbiest, Annelies, Diether Lambrechts, Thomas Van Brussel, et al.. (2018). Polymorphisms in the Von Hippel–Lindau Gene Are Associated With Overall Survival in Metastatic Clear-Cell Renal-Cell Carcinoma Patients Treated With VEGFR Tyrosine Kinase Inhibitors. Clinical Genitourinary Cancer. 16(4). 266–273. 8 indexed citations

12.

Verbiest, Annelies, Gabrielle Couchy, Sylvie Job, et al.. (2018). Molecular Subtypes of Clear-cell Renal Cell Carcinoma are Prognostic for Outcome After Complete Metastasectomy. European Urology. 74(4). 474–480. 41 indexed citations

13.

Vanmechelen, Maxime, Diether Lambrechts, Thomas Van Brussel, et al.. (2018). Fibroblast Growth Factor Receptor-2 Polymorphism rs2981582 is Correlated With Progression-free Survival and Overall Survival in Patients With Metastatic Clear-cell Renal Cell Carcinoma Treated With Sunitinib. Clinical Genitourinary Cancer. 17(2). e235–e246. 4 indexed citations

14.

Rebouissou, Sandra, Tiziana La Bella, Sandrine Imbeaud, et al.. (2017). Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro. Clinical Cancer Research. 23(15). 4364–4375. 48 indexed citations

15.

Verbiest, Annelies, Gabrielle Couchy, Sylvie Job, et al.. (2017). Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated With Outcome During Pazopanib Therapy in the Metastatic Setting. Clinical Genitourinary Cancer. 16(3). e605–e612. 38 indexed citations

16.

Couchy, Gabrielle, Alessia Bagattin, Tatiana Cañeque, et al.. (2017). Hepatocyte nuclear factor 1α suppresses steatosis-associated liver cancer by inhibiting PPARγ transcription. Journal of Clinical Investigation. 127(5). 1873–1888. 58 indexed citations

17.

Beuselinck, Benoit, Sylvie Job, Étienne Becht, et al.. (2015). Molecular Subtypes of Clear Cell Renal Cell Carcinoma Are Associated with Sunitinib Response in the Metastatic Setting. Clinical Cancer Research. 21(6). 1329–1339. 230 indexed citations

18.

Reyniès, Aurélien de, Marie‐Claude Jaurand, Annie Renier, et al.. (2014). Molecular Classification of Malignant Pleural Mesothelioma: Identification of a Poor Prognosis Subgroup Linked to the Epithelial-to-Mesenchymal Transition. Clinical Cancer Research. 20(5). 1323–1334. 100 indexed citations

19.

Gasnereau, Isabelle, Mathieu Boissan, Germain Margall-Ducos, et al.. (2011). KIF20A mRNA and Its Product MKlp2 Are Increased During Hepatocyte Proliferation and Hepatocarcinogenesis. American Journal Of Pathology. 180(1). 131–140. 53 indexed citations

20.

Rebouissou, Sandra, Gabrielle Couchy, Louis Libbrecht, et al.. (2008). The β-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. Journal of Hepatology. 49(1). 61–71. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact